Evaluating ER-100 for Safety in People With Glaucoma or Non-Arteritic Anterior Ischemic Optic Neuropathy (Optic Nerve Conditions)
Evaluating ER-100 for Safety in People With Glaucoma or Non-Arteritic Anterior Ischemic Optic Neuropathy (Optic Nerve Conditions)
Recruiting · NCT07290244 · Registry updated 2026-05-19Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluating ER-100 for Safety in People With Glaucoma or Non-Arteritic Anterior Ischemic Optic Neuropathy (Optic Nerve Conditions) | cranial nerve neuropathy, eye disorder, glaucoma, nervous system disorder, ocular hypertension, open-angle glaucoma, optic nerve disorder, retinal disorder | Recruiting | Phase 1 | 2026-05-19 | NCT07290244 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Life Biosciences Inc. | 1 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Charleston Neuroscience Institute | Charleston | United States | 1 |
| Columbia University Irving Medical Center/Edward S. Harkness Eye Institute | New York | United States | 1 |
| Global Research Management, Inc. | Glendale | United States | 7 |
| Mass Eye and Ear | Boston | United States | 7 |